The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Dopaminergic Stimulation of Myeloid Antigen-Presenting Cells Attenuates Signal Transducer and Activator of Transcription 3-Activation Favouring the Development of Experimental Autoimmune Encephalomyelitis
Abstract
The dual potential to promote tolerance or inflammation to self-antigens makes dendritic cells (DCs) fundamental players in autoimmunity. Previous results have shown that stimulation of dopamine receptor D5 (DRD5) in DCs potentiates their inflammatory behaviour, favouring the development of experimental autoimmune encephalomyelitis (EAE). Here we aimed to decipher the underlying mechanism and to test its relevance in multiple sclerosis (MS) patients. Our data shows that DRD5-deficiency confined to DCs in EAE mice resulted in reduced frequencies of CD4+ T-cell subsets with inflammatory potential in the central nervous system, including not only Th1 and Th17 cells, but also GM-CSF producers. Importantly, ex vivo depletion of dopamine from DCs resulted in a dramatic reduction of EAE severity, highlighting the relevance of an autocrine loop promoting inflammation in vivo. Mechanistic analyses indicated that DRD5-signalling in both mouse DCs and human monocytes involves the attenuation of STAT3-activation, a transcription factor that limits the production of the inflammatory cytokines IL-12 and IL-23. Furthermore, we found an exacerbated expression of all dopamine receptors in peripheral blood pro-inflammatory monocytes obtained from MS patients. These findings illustrate a novel mechanism by which myeloid antigen-presenting cells may trigger the onset of their inflammatory behaviour promoting the development of autoimmunity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Codarri, L., Gyülvészi, G., Tosevski, V., Hesske, L., Fontana, A., Magnenat, L., Suter, T., & Becher, B. (2011) · Nature Immunology · doi:10.1038/ni.2027 · Cited by 1,191 · cited 9×
“Thus, the pro-inflammatory cytokines IL-17, IFN-γ, and GM-CSF produced by CD4+ T-cells contribute to the development of EAE, although the latter plays a major role (14, 16).”
BackgroundMethodInfluentialMolecular neurobiology of dopaminergic receptors
Sibley, D. R., Monsma, F. J., & Shen, Y. (1993) · International review of neurobiology · doi:10.1016/s0074-7742(08)60573-5 · Cited by 255
CCR2 defines in vivo development and homing of IL-23-driven GM-CSF-producing Th17 cells
Kara, E. E., McKenzie, D. R., Bastow, C. R., Gregor, C. E., Fenix, K. A., Ogunniyi, A. D., Paton, J. C., Mack, M., Pombal, D. R., Seillet, C., et al. (2015) · Nature Communications · doi:10.1038/ncomms9644 · Cited by 136
Repurposing dopaminergic drugs for MS — the evidence mounts
Marino, F., & Cosentino, M. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.33 · Cited by 38
Self-citation
Research works printed but not linked: 64
- Ohnmacht, 2009, Constitutive ablation of dendritic cells breaks self-tolerance of CD4 T cells and results in spontaneous fatal autoimmunity, J Exp Med, 206, 549, 10.1084/jem.20082394 · DOI · Paper page
- Yoshida, 2014, The transcription factor IRF8 activates integrin-mediated TGF-beta signaling and promotes neuroinflammation, Immunity, 40, 187, 10.1016/j.immuni.2013.11.022 · DOI
- Lalor, 2011, Caspase-1-processed cytokines IL-1beta and IL-18 promote IL-17 production by gammadelta and CD4 T cells that mediate autoimmunity, J Immunol, 186, 5738, 10.4049/jimmunol.1003597 · DOI · Paper page
- Inoue, 2012, NLRP3 inflammasome induces chemotactic immune cell migration to the CNS in experimental autoimmune encephalomyelitis, Proc Natl Acad Sci U S A, 109, 10480, 10.1073/pnas.1201836109 · DOI · Paper page
- Mellanby, 2012, TLR-4 ligation of dendritic cells is sufficient to drive pathogenic T cell function in experimental autoimmune encephalomyelitis, J Neuroinflammation, 9, 248, 10.1186/1742-2094-9-248 · DOI
- Haines, 2013, Autoimmune memory T helper 17 cell function and expansion are dependent on interleukin-23, Cell Rep, 3, 1378, 10.1016/j.celrep.2013.03.035 · DOI
- O’Connor, 2013, T-bet is essential for Th1-mediated, but not Th17-mediated, CNS autoimmune disease, Eur J Immunol, 43, 2818, 10.1002/eji.201343689 · DOI
- Manicassamy, 2010, Activation of beta-catenin in dendritic cells regulates immunity versus tolerance in the intestine, Science, 329, 849, 10.1126/science.1188510 · DOI · Paper page
- Suryawanshi, 2015, Canonical wnt signaling in dendritic cells regulates Th1/Th17 responses and suppresses autoimmune neuroinflammation, J Immunol, 194, 3295, 10.4049/jimmunol.1402691 · DOI
- Hoentjen, 2005, STAT3 regulates NF-kappaB recruitment to the IL-12p40 promoter in dendritic cells, Blood, 105, 689, 10.1182/blood-2004-04-1309 · DOI
- Wagner, 2015, JAK1/STAT3 activation directly inhibits IL-12 production in dendritic cells by preventing CDK9/P-TEFb recruitment to the p35 promoter, Biochem Pharmacol, 96, 52, 10.1016/j.bcp.2015.04.019 · DOI
- Dardalhon, 2008, Role of Th1 and Th17 cells in organ-specific autoimmunity, J Autoimmun, 31, 252, 10.1016/j.jaut.2008.04.017 · DOI · Paper page
- Oukka, 2008, Th17 cells in immunity and autoimmunity, Ann Rheum Dis, 67, iii26, 10.1136/ard.2008.098004 · DOI
- Cravens, 2011, Lymph node-derived donor encephalitogenic CD4+ T cells in C57BL/6 mice adoptive transfer experimental autoimmune encephalomyelitis highly express GM-CSF and T-bet, J Neuroinflammation, 8, 73, 10.1186/1742-2094-8-73 · DOI
- Lee, 2015, Analysis of TGF-beta1 and TGF-beta3 as regulators of encephalitogenic Th17 cells: implications for multiple sclerosis, Brain Behav Immun, 46, 44, 10.1016/j.bbi.2014.12.007 · DOI
- Petermann, 2010, gammadelta T cells enhance autoimmunity by restraining regulatory T cell responses via an interleukin-23-dependent mechanism, Immunity, 33, 351, 10.1016/j.immuni.2010.08.013 · DOI · Paper page
- Fletcher, 2010, T cells in multiple sclerosis and experimental autoimmune encephalomyelitis, Clin Exp Immunol, 162, 1, 10.1111/j.1365-2249.2010.04143.x.CEI4143 · doi:10.1111/j.1365-2249.2010.04143.x.cei4143
- Varthaman, 2011, Physiological induction of regulatory Qa-1-restricted CD8+ T cells triggered by endogenous CD4+ T cell responses, PLoS One, 6, e21628, 10.1371/journal.pone.0021628 · DOI
- Najafian, 2003, Regulatory functions of CD8+CD28- T cells in an autoimmune disease model, J Clin Invest, 112, 1037, 10.1172/JCI17935 · DOI · Paper page
- Lee, 2008, Essential role of CD8+CD122+ regulatory T cells in the recovery from experimental autoimmune encephalomyelitis, J Immunol, 180, 825, 10.4049/jimmunol.180.2.825 · DOI
- Chen, 2009, Novel CD8+ Treg suppress EAE by TGF-beta- and IFN-gamma-dependent mechanisms, Eur J Immunol, 39, 3423, 10.1002/eji.200939441 · DOI
- Kalim, 2013, Prostaglandin E2 inhibits IL-23 and IL-12 production by human monocytes through down-regulation of their common p40 subunit, Mol Immunol, 53, 274, 10.1016/j.molimm.2012.08.014 · DOI
- Chiurchiu, 2016, Modulation of monocytes by bioactive lipid anandamide in multiple sclerosis involves distinct toll-like receptors, Pharmacol Res, 113, 313, 10.1016/j.phrs.2016.09.003 · DOI
- Pacheco, 2009, Role of dopamine in the physiology of T-cells and dendritic cells, J Neuroimmunol, 216, 8, 10.1016/j.jneuroim.2009.07.018 · DOI
- Pacheco, 2014, The dopaminergic system in autoimmune diseases, Front Immunol, 5, 117, 10.3389/fimmu.2014.00117 · DOI · Paper page
- Cosentino, 2013, Adrenergic and dopaminergic modulation of immunity in multiple sclerosis: teaching old drugs new tricks?, J Neuroimmune Pharmacol, 8, 163, 10.1007/s11481-012-9410-z · DOI
- Prado, 2013, Modulation of T-cell mediated immunity by dopamine receptor d5, Endocr Metab Immune Disord Drug Targets, 13, 184, 10.2174/1871530311313020007 · DOI
- Levite, 2017, Dopamine, T cells and multiple sclerosis (MS), J Neural Transm (Vienna), 124, 525, 10.1007/s00702-016-1640-4 · DOI
- Balkowiec-Iskra, 2007, Dopamine, serotonin and noradrenaline changes in the striatum of C57BL mice following myelin oligodendrocyte glycoprotein (MOG) 35-55 and complete Freund adjuvant (CFA) administration, Acta Neurobiol Exp (Wars), 67, 379, 10.55782/ane-2007-1655 · DOI
- Giorelli, 2005, Dopamine fails to regulate activation of peripheral blood lymphocytes from multiple sclerosis patients: effects of IFN-beta, J Interferon Cytokine Res, 25, 395, 10.1089/jir.2005.25.395 · DOI
- Zaffaroni, 2008, Therapy with interferon-beta modulates endogenous catecholamines in lymphocytes of patients with multiple sclerosis, Exp Neurol, 214, 315, 10.1016/j.expneurol.2008.08.015 · DOI
- Cosentino, 2012, Dopaminergic modulation of CD4+CD25(high) regulatory T lymphocytes in multiple sclerosis patients during interferon-beta therapy, Neuroimmunomodulation, 19, 283, 10.1159/000336981 · DOI
- Nakano, 2009, Dopamine released by dendritic cells polarizes Th2 differentiation, Int Immunol, 21, 645, 10.1093/intimm/dxp033 · DOI
- Prado, 2012, Stimulation of dopamine receptor D5 expressed on dendritic cells potentiates Th17-mediated immunity, J Immunol, 188, 3062, 10.4049/jimmunol.1103096 · DOI · Paper page
- Hollon, 2002, Mice lacking D5 dopamine receptors have increased sympathetic tone and are hypertensive, J Neurosci, 22, 10801, 10.1523/JNEUROSCI.22-24-10801.2002 · DOI · Paper page
- Hochweller, 2008, A novel CD11c.DTR transgenic mouse for depletion of dendritic cells reveals their requirement for homeostatic proliferation of natural killer cells, Eur J Immunol, 38, 2776, 10.1002/eji.200838659 · DOI · Paper page
- Ning, 2001, Signal transducer and activator of transcription 3 activation is required for Asp(816) mutant c-Kit-mediated cytokine-independent survival and proliferation in human leukemia cells, Blood, 97, 3559, 10.1182/blood.V97.11.3559 · DOI
- Donas, 2016, The histone demethylase inhibitor GSK-J4 limits inflammation through the induction of a tolerogenic phenotype on DCs, J Autoimmun, 75, 105, 10.1016/j.jaut.2016.07.011 · DOI
- Franz, 2015, Dopamine receptors D3 and D5 regulate CD4(+)T-cell activation and differentiation by modulating ERK activation and cAMP production, J Neuroimmunol, 284, 18, 10.1016/j.jneuroim.2015.05.003 · DOI
- Polman, 2005, Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald criteria”, Ann Neurol, 58, 840, 10.1002/ana.20703 · DOI · Paper page
- Kurtzke, 1983, Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS), Neurology, 33, 1444, 10.1212/WNL.33.11.1444 · DOI · Paper page
- Kustrimovic, 2014, Expression of dopaminergic receptors on human CD4+ T lymphocytes: flow cytometric analysis of naive and memory subsets and relevance for the neuroimmunology of neurodegenerative disease, J Neuroimmune Pharmacol, 9, 302, 10.1007/s11481-014-9541-5 · DOI
- Helft, 2015, GM-CSF mouse bone marrow cultures comprise a heterogeneous population of CD11c(+)MHCII(+) macrophages and dendritic cells, Immunity, 42, 1197, 10.1016/j.immuni.2015.05.018 · DOI · Paper page
- Duplomb, 2008, Interleukin-6 inhibits receptor activator of nuclear factor kappaB ligand-induced osteoclastogenesis by diverting cells into the macrophage lineage: key role of Serine727 phosphorylation of signal transducer and activator of transcription 3, Endocrinology, 149, 3688, 10.1210/en.2007-1719 · DOI
- Giannelli, 2008, A six-color flow cytometric assay for the analysis of peripheral blood dendritic cells, Cytometry B Clin Cytom, 74, 349, 10.1002/cyto.b.20434 · doi:10.1002/cyto.b.20434
- Mukherjee, 2015, Non-classical monocytes display inflammatory features: validation in sepsis and systemic lupus erythematous, Sci Rep, 5, 13886, 10.1038/srep13886 · DOI · Paper page
- Cosentino, 2007, Human CD4+CD25+ regulatory T cells selectively express tyrosine hydroxylase and contain endogenous catecholamines subserving an autocrine/paracrine inhibitory functional loop, Blood, 109, 632, 10.1182/blood-2006-01-028423 · DOI · Paper page
- Nakano, 2008, Antagonizing dopamine D1-like receptor inhibits Th17 cell differentiation: preventive and therapeutic effects on experimental autoimmune encephalomyelitis, Biochem Biophys Res Commun, 373, 286, 10.1016/j.bbrc.2008.06.012 · DOI
- Nakano, 2011, Dopamine induces IL-6-dependent IL-17 production via D1-like receptor on CD4 naive T cells and D1-like receptor antagonist SCH-23390 inhibits cartilage destruction in a human rheumatoid arthritis/SCID mouse chimera model, J Immunol, 186, 3745, 10.4049/jimmunol.1002475 · DOI · Paper page
- Nakashioya, 2011, Therapeutic effect of D1-like dopamine receptor antagonist on collagen-induced arthritis of mice, Mod Rheumatol, 21, 260, 10.1007/s10165-010-0387-2 · doi:10.1007/s10165-010-0387-2
- Nakagome, 2011, Dopamine D1-like receptor antagonist attenuates Th17-mediated immune response and ovalbumin antigen-induced neutrophilic airway inflammation, J Immunol, 186, 5975, 10.4049/jimmunol.1001274 · DOI
- Gong, 2013, Blockade of dopamine D1-like receptor signalling protects mice against OVA-induced acute asthma by inhibiting B-cell activating transcription factor signalling and Th17 function, FEBS J, 280, 6262, 10.1111/febs.12549 · doi:10.1111/febs.12549
- Hashimoto, 2009, Dopamine D1-like receptor antagonist, SCH23390, exhibits a preventive effect on diabetes mellitus that occurs naturally in NOD mice, Biochem Biophys Res Commun, 383, 460, 10.1016/j.bbrc.2009.04.034 · DOI
- Okada, 2009, D1-like receptor antagonist inhibits IL-17 expression and attenuates crescent formation in nephrotoxic serum nephritis, Am J Nephrol, 30, 274, 10.1159/000225902 · DOI
- Tuohy, 2000, Epitope spreading: a mechanism for progression of autoimmune disease, Arch Immunol Ther Exp (Warsz), 48, 347
- Naviglio, 2010, Leptin potentiates antiproliferative action of cAMP elevation via protein kinase A down-regulation in breast cancer cells, J Cell Physiol, 225, 801, 10.1002/jcp.22288 · DOI
- Spina, 2012, cAMP elevation down-regulates beta3 integrin and focal adhesion kinase and inhibits leptin-induced migration of MDA-MB-231 breast cancer cells, Biores Open Access, 1, 324, 10.1089/biores.2012.0270 · DOI
- Zouein, 2015, Pivotal importance of STAT3 in protecting the heart from acute and chronic stress: new advancement and unresolved issues, Front Cardiovasc Med, 2, 36, 10.3389/fcvm.2015.00036 · DOI · Paper page
- Matsushita, 2008, Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression, J Clin Invest, 118, 3420, 10.1172/JCI36030 · DOI · Paper page
- Matsushita, 2010, Regulatory B cells (B10 cells) and regulatory T cells have independent roles in controlling experimental autoimmune encephalomyelitis initiation and late-phase immunopathogenesis, J Immunol, 185, 2240, 10.4049/jimmunol.1001307 · DOI · Paper page
- Kowalczyk, 2014, Cell-extrinsic CTLA4-mediated regulation of dendritic cell maturation depends on STAT3, Eur J Immunol, 44, 1143, 10.1002/eji.201343601 · DOI
- Goverman, 2009, Autoimmune T cell responses in the central nervous system, Nat Rev Immunol, 9, 393, 10.1038/nri2550 · DOI · Paper page
- Carson, 2006, CNS immune privilege: hiding in plain sight, Immunol Rev, 213, 48, 10.1111/j.1600-065X.2006.00441.x · DOI · Paper page
- Meye, 2014, The vital role of constitutive GPCR activity in the mesolimbic dopamine system, Transl Psychiatry, 4, e361, 10.1038/tp.2013.130 · DOI
Cited by
Dopamine, Immunity, and Disease
Channer, B., Matt, S. M., Nickoloff-Bybel, E. A., Pappa, V., Agarwal, Y., Wickman, J., & Gaskill, P. J. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000618 · Cited by 308
Matt, S. M., & Gaskill, P. J. (2020) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-019-09851-4 · Cited by 287
Metadata
- Authors
- Prado, C., Gaiazzi, M., González, H., Ugalde, V., Figueroa, A., Osorio-Barrios, F. J., López, E., Lladser, A., Rasini, E., Marino, F., Zaffaroni, M., Cosentino, M., & Pacheco, R.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2018-03-21
- Volume
- 9
- ISSN
- 1664-3224
- Cited by
- 43
- References
- 4
- Funders
- Corporación de Fomento de la Producción (INNOVA 12IDL2-16030)
- Fondo Nacional de Desarrollo Científico y Tecnológico (1170093, 1171703, 3160383)
- Fondo de Fomento al Desarrollo Científico y Tecnológico (ID16I10369)
- Comisión Nacional de Investigación Científica y Tecnológica (PFB-16, 22150983)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.